The U.S. Food and Drug Administration halted imports of drug ingredients made by a Chinese drug manufacturer after a massive recall of one of its drugs over cancer-causing ingredients.
China’s Zhejiang Huahai Pharmaceuticals, a bulk manufacturer of the heart and blood pressure medicine valsartan, recalled the product in the United States in July after the presence of N-nitrosodimethylamine (NDMA) was found.
